The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review

SM Szabo, RM Salhany, A Deighton… - Orphanet Journal of …, 2021 - Springer
Background Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited
neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The …

Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy

M Iftikhar, J Frey, MJ Shohan, S Malek… - Pharmacology & …, 2021 - Elsevier
Many neuromuscular diseases are genetically inherited or caused by mutations in motor
function proteins. Two of the most prevalent neuromuscular diseases are Duchenne …

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert …

AC Goldberg, PN Hopkins, PP Toth… - Journal of clinical …, 2011 - Elsevier
The familial hypercholesterolemias (FH) are a group of genetic defects resulting in severe
elevations of blood cholesterol levels and increased risk of premature coronary heart …

Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy

PP Laurila, P Luan, M Wohlwend, N Zanou, B Crisol… - Science …, 2022 - science.org
Duchenne muscular dystrophy (DMD), the most common muscular dystrophy, is a severe
muscle disorder, causing muscle weakness, loss of independence, and premature death …

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse

N Wein, TA Vetter, A Vulin, TR Simmons… - … Therapy-Methods & …, 2022 - cell.com
Duchenne muscular dystrophy (DMD) is typically caused by mutations that disrupt the DMD
reading frame, but nonsense mutations in the 5′ part of the gene induce utilization of an …

[HTML][HTML] Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies

E Le Rumeur - Bosnian journal of basic medical sciences, 2015 - ncbi.nlm.nih.gov
Mutations of the dystrophin DMD gene, essentially deletions of one or several exons, are the
cause of two devastating and to date incurable diseases, Duchenne (DMD) and Becker …

Mechanisms of myofibre death in muscular dystrophies: the emergence of the regulated forms of necrosis in myology

M Bencze - International Journal of Molecular Sciences, 2022 - mdpi.com
Myofibre necrosis is a central pathogenic process in muscular dystrophies (MD). As post-
lesional regeneration cannot fully compensate for chronic myofibre loss, interstitial tissue …

From fiction to science: clinical potentials and regulatory considerations of gene editing

M Schacker, D Seimetz - Clinical and translational medicine, 2019 - Springer
Gene editing technologies such as CRISPR/Cas9 have emerged as an attractive tool not
only for scientific research but also for the development of medicinal products. Their ability to …

Cardiac MRI biomarkers for Duchenne muscular dystrophy

P Magrath, N Maforo, P Renella, SF Nelson… - Biomarkers in …, 2018 - Taylor & Francis
Duchenne muscular dystrophy (DMD) is a fatal inherited genetic disorder that results in
progressive muscle weakness and ultimately loss of ambulation, respiratory failure and …

Sports genetics moving forward: lessons learned from medical research

CM Mattsson, MT Wheeler, D Waggott… - Physiological …, 2016 - journals.physiology.org
Sports genetics can take advantage of lessons learned from human disease genetics. By
righting past mistakes and increasing scientific rigor, we can magnify the breadth and depth …